Evidence map›Paper›PMID 19620426›Full record

ReviewAJR. American journal of roentgenology2009

In vivo MRI cell tracking: clinical studies.

Jeff W M Bulte

Open access · greenAbstract readReview
In one paragraph

Review in AJR. American journal of roentgenology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 202 papers.

0numbers the graph read from it
0cells of the map it votes in
202citing papers in PubMed
29.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

202 citing papers in PubMed, 425 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Magnetic Cell Targeting for Cardiovascular Tissue Engineering.Tissue engineering. Part B, Reviews · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

142 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Jeff W M BulteRussell H. Morgan Department of Radiology, Division of MR Research, Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. jwmbulte@mri.jhu.edu
Johns Hopkins University · US

Funding

MR Tracking of Magnetically Labeled Stem Cells in CNSR01NS045062 · NINDS · JOHNS HOPKINS UNIVERSITY · PI BULTE, JEFF W. · 2003 to 2013
$4.4M
Developing a CEST Reporter Gene (RMI)R21EB005252 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI BULTE, JEFF W. · 2005 to 2008
$1.4M
Developing MPI for Non-Invasive and Quantitative Imaging of Stem CellsR01DA026299 · NIDA · JOHNS HOPKINS UNIVERSITY · PI BULTE, JEFF W. · 2008 to 2011
$1.3M
MR-Guided Delivery and Monitoring of Magnetocapsules Immunoprotecting Islet CellsR01EB007825 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI BULTE, JEFF W. · 2007 to 2008
$992k
NIBIB NIH HHS R01 EB007825NIBIB NIH HHS R21 EB005252NIDA NIH HHS R01 DA026299NIDA NIH HHS R01 DA02699NINDS NIH HHS R01 NS045062
6 · The paper itself

Abstract

objectiveThe purpose of this review is to describe the principles of MRI cell tracking with superparamagnetic iron oxides and the four clinical trials that have been performed.

conclusionClinical MRI cell tracking is likely to become an important tool at the bedside once (stem) cell therapy becomes mainstream. The most prominent role of this technique probably will be verification of accurate cell delivery with MRI-guided injection, in which interventional radiologists will play a role in the near future. All clinical studies described as of this writing have been performed outside the United States.

Indexed as

Contrast MediaFerric CompoundsAdultAgedAnimalsCancer VaccinesCell MovementCell TransplantationDendritic CellsFemaleHumansImmunotherapyLymphatic MetastasisMagnetic Resonance ImagingMaleMelanomaCancer VaccinesContrast MediaFerric Compoundsferric oxide

Identifiers

PMID19620426
PMCPMC2857985
OpenAlexW2052324533

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.